We previously reported that etanercept (an anti-TNF-α agent that binds to and functionally inactivates TNF-α) improved endothelial function in rats with diabetes mellitus [19], however, its effects on obesity-related vascular dysfunction remain unclear. This evidence concerns the gene TNF and obesity disorder.